Literature DB >> 9788607

E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families.

A Keirsebilck1, S Bonné, E Bruyneel, P Vermassen, E Lukanidin, M Mareel, F van Roy.   

Abstract

Metastasin is putatively associated with cytoskeletal proteins and may influence cell motility, although its exact physiological role is not known. Because E-cadherin is an invasion suppressor molecule, and metastasin a metastasis-inducing molecule, we wondered which molecule was playing a dominant role in the balance that finally leads to noninvasiveness or invasiveness. The expression levels of E-cadherin and metastasin were monitored in two mouse tumor cell families and were found to be inversely regulated. Moreover, overexpression obtained via transfection of plasmids coding for either one of these two molecules abrogated expression of the other molecule as investigated via Northern and Western blotting experiments. Invasiveness was accordingly influenced. Expression levels of alpha- and beta-catenins were not influenced by up-regulated metastasin, but their intracellular distribution was disturbed. The present results suggest that metastasin-induced invasiveness of several malignant tumor cells is at least partially caused by down-regulation of E-cadherin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788607

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.

Authors:  Kristin Andersen; Hidetoshi Mori; Jimmie Fata; Jamie Bascom; Tove Oyjord; Gunhild M Mælandsmo; Mina Bissell
Journal:  Dev Biol       Date:  2010-12-31       Impact factor: 3.582

3.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 4.  S100A4 and metastasis: a small actor playing many roles.

Authors:  Kjetil Boye; Gunhild M Maelandsmo
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

5.  Mts1 Up-regulation is Associated With Aggressive Pathological Features in Thyroid Cancer.

Authors:  Min Gyeong Cheon; Ye Won Son; Joon-Hyop Lee; Ho Hee Jang; Yoo Seung Chung
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

6.  S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity.

Authors:  Hong-Yan Zhang; Xian-Zhao Zheng; Xin-Hua Wang; Xiao-Yan Xuan; Feng Wang; Shan-Shan Li
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

7.  Genetic characterization of vocal fold lesions: leukoplakia and carcinoma.

Authors:  Rebecca S Bartlett; W Wesley Heckman; Jason Isenberg; Susan L Thibeault; Seth H Dailey
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

8.  Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Jianing Xu; Neil Gross; Yuanwei Zang; Shengda Cao; Feilong Yang; Zheng Yang; Wenbin Yu; Dapeng Lei; Xinliang Pan
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

Review 9.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

10.  S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.

Authors:  Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.